Unlikely to cause harm — often a labeling or packaging issue.
Tablets/Capsules Imprinted with Wrong ID
| Brand name | DOXAZOSIN MESYLATE |
| Generic name | DOXAZOSIN MESYLATE |
| Active ingredient(s) | DOXAZOSIN MESYLATE |
| Distributed by / for | Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA |
| NDC | 29300-353-10 |
| Full product label | Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10. |
| Recalling firm | Unichem Pharmaceuticals USA Inc. |
| Distribution | Nationwide |
| Quantity | 60,000 tablets |
| Recall initiated | 2026-01-21 |
| Report date | 2026-02-18 |
| Recall completed | — |
| Recall number | D-0306-2026 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | East Brunswick NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗